Intermittent Claudication

(redirected from claudication)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

intermittent claudication

[‚in·tər¦mit·ənt klȯ·də′kā·shən]
Cramping pain or weakness in the lower extremities during exercise, caused by occlusion of the arteries.

Intermittent Claudication


pain in the gastrocnemius muscles during walking, caused by insufficient blood supply to the lower extremities. It was described by J. M. Charcot in 1858.

References in periodicals archive ?
Conclusion: The elasticity of healthy tendon decreased with intermittent claudication in patients.
We have known for years that patients with claudication pain get the same benefits from a physician-supervised exercise program as from a procedure--and sometimes better.
Notice of Retraction: Potential vascular mechanisms of ramipril induced increases in walking ability in patients with intermittent claudication.
In this study we found no significant difference in the incidence of diabetic foot, ECG changes or intermittent claudication in those patients who had better diabetic control compared to those whose blood sugar levels were less well controlled.
The report provides a snapshot of the global therapeutic landscape of Intermittent Claudication
8) Most importantly, the above lesions rarely cause symptoms of claudication.
Week Two: Walk to the point of claudication, stop and rest, then return home and immediately repeat the walk again.
At tentative diagnosis of neurogenic claudication due to degenerative lumbar spinal stenosis was given and a treatment program of flexion-distraction/ side posture spinal mobilization/ manipulation, neural mobilization, flexion based home exercises including a progressive stationary cycling program was prescribed.
This should begin with a detailed history of the patient's claudication symptoms.
However, if you know that you have cardiac disease, are addressing your cardiovascular risk factors, and don't have claudication or rest pain, you don't need to be evaluated for PAD.
Medications used for intermittent claudication usually aim to relieve the pain, improve functioning, and prevent progression that might lead to gangrene and amputation, and also to prevent heart disease and stroke, reduce artery damage and improve cholesterol and lipid levels.
Cell therapies company Pluristem Therapeutics Inc (TASE:PLTR) said on Wednesday that it has received the approval to initiate a Phase II study using its PLacental eXpanded (PLX) cells in the treatment of Intermittent Claudication (IC), a subset of peripheral artery disease (PAD), in Israel.